Cardiac MRI evaluation of myocardial disease

  title={Cardiac MRI evaluation of myocardial disease},
  author={Gabriella Captur and Charlotte H. Manisty and James C. Moon},
  pages={1429 - 1435}
Cardiovascular magnetic resonance (CMR) is a key imaging technique for cardiac phenotyping with a major clinical role. It can assess advanced aspects of cardiac structure and function, scar burden and other myocardial tissue characteristics but there is new information that can now be derived. This can fill many of the gaps in our knowledge with the potential to change thinking, disease classifications and definitions as well as patient care. Established techniques such as the late gadolinium… 

Figures and Tables from this paper

T1 mapping in cardiac MRI

The physics involved in estimating T1 times is outlined, the disease-specific clinical and research impacts of T1 and ECV to date are summarized, and some of the remaining challenges such as their community-wide delivery, quality control, and standardization for clinical practice are highlighted.

Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography

CMR and CT can estimate ECV and in turn diffuse myocardial fibrosis, obviating the need for invasive endomyocardial biopsy and generating new biological insights into key cardiac diseases.

Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)

This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.

Myocardial Imaging with CMR Parametric Mapping: Clinical Applications

Cardiovascular magnetic resonance parametric mapping techniques are useful in the evaluation of multiple conditions, including iron overload, amyloid infiltration, glycosphingolipid accumulation, myocardial edema, and fibrosis.

Established and Emerging Cardiovascular Magnetic Resonance Imaging Techniques in the Evaluation of Subclinical Cardiovascular Disease

Aortic distensibility and left ventricular mass improve significantly in newly diagnosed RA patients following treatment and Etanercept appears to offer additional benefit over standard treatment evidenced by numerical improvements in aorticdistensibility.

Quantitative Tissue Characterization in Pediatric Cardiology

Advanced CMR mapping techniques underlie a rapid development and enable a noninvasive characterization of the myocardium and have the potential to become key imaging tools in pediatric patients.

When should we use contrast material in cardiac MRI?

An overview of when to use contrast material in cardiac and cardiac‐related vascular MRI is provided, the major imaging building blocks are summarized, and the diagnostic value of the available contrast‐enhanced and noncontrast techniques are described.

Myocardial T2* Mapping with Ultrahigh Field Magnetic Resonance: Physics and Frontier Applications

Myocardial T2* mapping at ultrahigh magnetic fields is introduced as a promising technique to non-invasively assess myocardial (patho)physiology in vivo.

Molecular Imaging to Monitor Left Ventricular Remodeling in Heart Failure

Novel imaging techniques can provide a precise and accurate visualization of the myocardium and for the detection of alternations at molecular level, and molecular-targeted imaging of biological processes involved in heart failure is feasible.

Molecular Approaches and Echocardiographic Deformation Imaging in Detecting Myocardial Fibrosis

Two-dimensional speckle tracking echocardiography (STE) has emerged as a new non-invasive imaging modality, able to detect myocardial tissue abnormalities without specifying the causes of the underlying histopathological changes, and its main technical limitations and criticisms are highlighted.



Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement

This document provides recommendations for clinical and research T1 and ECV measurement, based on published evidence when available and expert consensus when not, and addresses controversies in the field.

Clinical cardiac magnetic resonance spectroscopy.

Performance of T1 and T2 Mapping Cardiovascular Magnetic Resonance to Detect Active Myocarditis in Patients With Recent-Onset Heart Failure

T2 mapping seems to be superior when compared with standard CMR parameters, global myocardial T1, and extracellular volume fraction values for assessing the activity of myocarditis in patients with recent-onset heart failure and reduced left ventricular function.

Diffusion MRI in the heart

The solutions and approaches that have been developed to enable diffusion MRI of the heart in vivo, including a dual‐gated stimulated echo approach, a velocity‐ (M1) or an acceleration‐(M2) compensated pulsed gradient spin echo Approach, and the use of principal component analysis filtering are described.

Population-based studies of myocardial hypertrophy: high resolution cardiovascular magnetic resonance atlases improve statistical power

High spatial resolution CMR with automated phenotyping provides greater power for mapping wall thickness than conventional 2D imaging and enables a reduction in the sample size required for studies of environmental and genetic determinants of LV wall thickness.

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

Transmural LGE is determined reliably by PSIR and represents advanced cardiac amyloidosis and the PSIR technique provides incremental information on outcome even after adjustment for known prognostic factors.

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Reversible myocardial dysfunction can be identified by contrast-enhanced MRI before coronary revascularization and is strongly related to the degree of improvement in the global mean wall-motion score and the ejection fraction after Revascularization.